Quebec product in Bausch + Lomb’s portfolio

Sunday, August 4 2013 | 00 h 00 min | News

Mimetogen, a Montréal pharmaceutical company, has granted Bausch + Lomb an option to license MIM-D3, a treatment for dry-eye syndrome Without...

Read More

Valeant buys Bausch + Lomb

Tuesday, May 28 2013 | 00 h 00 min | News

The Quebec pharmaceutical Valeant has acquired Bausch + Lomb, the global leader in eye health, for $87 billion Half of the payment will go directly...

Read More

Bausch + Lomb and CROMA fight blindness in Africa

Monday, January 28 2013 | 00 h 00 min | News

Light for the World, the Austrian organization that helps people who have no access to basic eye care, has received support in its fight against...

Read More

Three suitors for Bausch + Lomb

Monday, January 7 2013 | 00 h 00 min | News

 According to specialized news website Bloomberg, Abbott Laboratories, Johnson & Johnson and Sanofi are in the running to acquire Bausch + Lomb,...

Read More

Contact Lens Institute & IACLE Collaborate to Bring Practice and Patient Insights to Contact Lens Educators

Friday, April 19 2024 | 15 h 12 min | News

The Contact Lens Institute (CLI) and the International Association of Contact Lens Educators (IACLE) announced a collaboration to provide...

Read More